Jithin Yohannan
NEW YORK — A greater percentage of glaucoma patients who received two iStent injects in conjunction with phacoemulsification had no need for IOP-lowering medication than patients who received two iStents and underwent cataract surgery, according to a poster presentation at the American Glaucoma Society annual meeting.
The retrospective, investigational, single-center cohort study aimed to compare the ability of the first-generation iStent and second-generation iStent inject (both Glaukos) to reduce medication burden as well as to assess demographic and ocular factors in
Uncategorized